dextroamphetamine has been researched along with ngb 2904 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Logue, AD; McNamara, RK; Newman, AH; Pritchard, LM; Richtand, NM; Taylor, B; Welge, JA; Xu, M; Zhang, J | 1 |
1 other study(ies) available for dextroamphetamine and ngb 2904
| Article | Year |
|---|---|
The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion.
Topics: Animals; Behavior, Animal; Dextroamphetamine; Dopamine Antagonists; Fluorenes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Piperazines; Receptors, Dopamine D3 | 2007 |